Crown Bioscience Inc.
Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds
CrownBio's scientists will present 13 scientific posters describing their latest research efforts, including generation of novel models for combinatory chemotherapy and immunotherapy studies, creation of 3D screening panels for improved efficacy assessments, demonstration of a checkpoint immunotherapy modulating intestinal microbiota, among other innovative developments in cancer therapeutics and preclinical pharmacology evaluation.
On Saturday October 28th , Crown Bioscience's Dr. Henry Li will deliver an oral presentation entitled, "Transcriptomic analysis of patient-derived xenografts reveals heterogeneity in human and mouse stroma/immune compartments" , as part of the conference's Challenges and Opportunities of Genomic Based Clinical Trials Plenary Session.
"I am excited to share Crown Bioscience's cutting-edge research with colleagues at AACR- NCI-EORTC," said Dr. Henry Li, Crown Bioscience's Vice President of Translational Oncology. "The data presented will exhibit the utility of our clinically relevant PDX models to identify critical biomarkers and improve preclinical evaluation of cancer therapies."
"Crown Bioscience is honored to play a leading role in presenting opportunities for scientific advancements at AACR-NCI-EORTC," said Laurie Heilmann, Chief Business Officer. "The work of our dedicated scientific team exemplifies Crown Bioscience's commitment to helping researchers solve global health challenges through continued innovation of our scientific translational platform."
Delegates can request copies of the posters and learn more about Crown Bioscience's scientific translational platform at booth 601.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
The Stevie Awards23.4.2018 04:02 | pressemeddelelse
Winners in 2018 Asia-Pacific Stevie® Awards Announced
Abeona Therapeutics Inc20.4.2018 14:16 | pressemeddelelse
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease
Taconic Biosciences20.4.2018 14:02 | pressemeddelelse
Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska
Diesel Technology Forum20.4.2018 00:10 | pressemeddelelse
Progress and Potential for Achieving Cleaner Air on a Global Basis
Aryaka19.4.2018 18:56 | pressemeddelelse
SD-WAN for Office 365: Aryaka Helps eLearning company, City & Guilds Group, Improve Office 365 Application Response Time
Taconic Biosciences19.4.2018 14:02 | pressemeddelelse
Taconic Biosciences Launches New Inflammatory Bowel Disease Models
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum